Lotus Health Group Co (600186) Fair Value & Analysis
Consumer Defensive · CN · Market cap 17.2B CNY (≈ $2.6B) · ISIN CNE000000WY0
What is Lotus Health Group Co really worth?
A solid business, but trading 242% above our fair value of ¥3.47.
Strengths
Risks
Fair value as of: Aug 24, 2026
From 25 valuation models · updated 12 days ago
Share price +24.0% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (¥4.53). The favourable scenario is already priced in.
- Solid but not exceptional quality (62/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 24, 2026.
How to read this chart
60‑month range ¥2.07 – ¥15.60 · fair‑value band ¥2.53 – ¥4.53 · the ¥11.88 price screens above the ¥3.47 fair value. Dashed = 300-day average. As of Aug 24, 2026.
Analysis
Lotus Health Group Co (600186) currently trades at ¥11.88, while our model-based Fair Value estimate is ¥3.47, implying the stock looks roughly 242.3% overvalued today. The Quality Score stands at 62/100 (solid quality), in the Consumer Defensive sector. Bull case: the Multiples group reads highest at a median of ¥3.62 per share, and 0 of the 25 models we run sit above the ¥11.88 price. Bear case: the Asset-Based group reads lowest at ¥0.7300, and 25 of the 25 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Lotus Health Group Co generated revenue of 3.7B CNY at a net margin of 9.6%. Revenue grew 28.0% year over year. It earns a return on equity of 20.3%. The balance sheet holds a net cash position of 1.1B CNY. Fundamentals as of Aug 24, 2026
Our scenario range runs from ¥2.53 (bear case) to ¥4.53 (bull case); at ¥11.88, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 13% below its 52-week high and 126% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −27% fair-value upside, at −71%, 600186 screens richer than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly ¥0.1421 per share, which is 4.1 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 25 models by family
Widest divergence: Multiples (¥3.62) versus Dividend Discount (¥0.2400). Highest evidence: FCF DCF (82).
Notify me when 600186 reaches fair value
Put 600186 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 24, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 61 · Market factors (momentum, volatility) 71
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Lotus Holdings Co.,Ltd. engages in the production and sale of condiments and health food in China. The company offers soy sauce, oyster sauce, vinegar, cooking wine, braised sauce, and sesame oil; chicken essence, chicken powder, chicken juice, seasoning, dumpling materials, fried vegetables, and fresh mushroom, as well as octagonal, white pepper, black …
Full company description
Lotus Holdings Co.,Ltd. engages in the production and sale of condiments and health food in China. The company offers soy sauce, oyster sauce, vinegar, cooking wine, braised sauce, and sesame oil; chicken essence, chicken powder, chicken juice, seasoning, dumpling materials, fried vegetables, and fresh mushroom, as well as octagonal, white pepper, black pepper, ang cumin powder. It also provides amino acid condiments; drinking water products; and tomato sauce, matsutake with blanched sauce, hot pot base, hot pot seasoning, crayfish seasoning, fondue with butter, chafing dish base, fish seasoning, edible alkali, baking soda, bread crumbs, and sesame sauce. The company was formerly known as Lotus Health Group Company and changed its name to Lotus Holdings Co.,Ltd. in May 2024. Lotus Holdings Co.,Ltd. was founded in 1983 and is based in Xiangcheng, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Lotus Health Group Co reported revenue of 3.5B CNY in FY2025 versus 1.8B CNY in FY2021, a compound +17.4%/yr. Reported net income was 309M CNY in FY2025, compounding +62.5%/yr from FY2021.
600186 screens 242% overvalued. Compare with Nestlé S.A →
Peer Group
Packaged Foods · 648 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 45/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Aug 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NESN | CHF 78.62 | CHF 57.26 | −27% |
| Danone S.A BN | €64.28 | €48.41 | −25% |
| Nestlé India Limited NESTLEIND | ₹1,478 | ₹251.94 | −83% |
| The Kraft Heinz Company KHC | $25.13 | $24.59 | −2% |
| Foshan Haitian Flavouring and Food Company 603288 | ¥35.05 | ¥21.93 | −37% |
| Inner Mongolia Yili Industrial Group 600887 | ¥25.51 | ¥32.50 | +27% |
| Yihai Kerry Arawana Holdings 300999 | ¥25.28 | ¥9.89 | −61% |
| General Mills, Inc GIS | $40.44 | $28.32 | −30% |
| Wilmar International Limited F34 | 3.64 SGD | 3.89 SGD | +7% |
| Britannia Industries Limited BRITANNIA | ₹5,511 | ₹1,765 | −68% |
Compare Lotus Health Group Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Lotus Health Group Co (600186) overvalued or undervalued?
What is the fair value of 600186?
What is the quality score of 600186?
What is the revenue of Lotus Health Group Co (600186)?
What is the net profit margin of 600186?
Does Lotus Health Group Co pay a dividend?
Watch Lotus Health Group Co in the live analysis
One click puts Lotus Health Group Co on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.